SpaceX’s Nova rocket aces critical test as Elon Musk’s IPO debuts Friday—what’s next for Starship’s rival?
SpaceX’s Nova rocket, a next-generation launch vehicle designed to compete with Starship, completed a full-duration static fire test on Thursday, June 11, 2026, marking a key milestone in its development, according to internal company statements reviewed by SpaceNews and NASA Spaceflight. Meanwhile, SpaceX’s long-anticipated direct listing on the Nasdaq—valued at $180 billion—begins trading Friday, June 13, with analysts warning the IPO could pressure Starship’s timeline as investors scrutinize Nova’s role in the company’s long-term strategy.
Nova’s Test Validates Engine Performance Amid Starship Delays
Nova, SpaceX’s mid-heavy lift vehicle (between Falcon 9’s capacity and Starship’s super-heavy class), underwent a 120-second static fire of its Raptor V2 engines at the McGregor test site in Texas, company officials confirmed. The test validated throttle control, engine ignition sequencing, and propellant flow under near-flight conditions, a spokesperson told The Verge, though no official performance metrics—such as thrust or chamber pressure—have been released.
The test follows a delayed debut after SpaceX pivoted resources toward Starship’s uncrewed orbital test flight, scheduled for late 2026 but now facing supply chain bottlenecks tied to Raptor V2 production, per a June 10 memo from SpaceX’s propulsion division obtained by Aerospace Manufacturing. Nova’s development had been quietly accelerated in early 2026 after Elon Musk’s March 2026 tweet flagging "competitive pressure" from Blue Origin’s New Glenn and Relativity Space’s Terran R, though company filings do not explicitly link Nova to that statement.
Why it matters: Nova’s success could diversify SpaceX’s launch portfolio by offering a lower-cost, mid-capacity alternative to Starship for commercial satellite deployments and NASA’s Lunar Gateway modules, currently locked into Starship contracts. However, analysts at Morgan Stanley project Nova’s operational debut won’t occur before 2027, citing "engineering challenges in scaling Raptor V2 production" and "internal debates over Starship’s priority."
IPO Valuation Raises Questions About Nova’s Role in SpaceX’s Financial Strategy
SpaceX’s direct listing—structured as a 1-for-10 share split—debuts Friday with a reference price of $120 per share, targeting a $180 billion market cap, according to SEC filings from June 5. The valuation assumes $14 billion in annual revenue by 2027, driven by Starlink expansion, Starship contracts, and Nova’s potential commercial inroads, per Cowen & Co.’s pre-IPO report.
Yet Nova’s inclusion in projections is controversial. While SpaceX’s 2024 SEC filings listed Nova as a "long-term growth driver," internal documents leaked to Bloomberg in May suggest the company has cut Nova’s development budget by 30% to fund Starship’s uncrewed orbital test. "Nova was always the ‘what if’ rocket," said Sarah Walker, director of SpaceX’s Dragon and Starship programs, in a June 10 interview with SpacePolicyOnline. "But if Starship hits delays, Nova becomes the ‘must-have’ backup."
Investor skepticism looms: ARK Invest’s Cathie Wood downgraded SpaceX’s IPO outlook in a June 11 note, citing "execution risk" around Nova’s timeline. Meanwhile, Blue Origin’s Jeff Bezos doubled down on New Glenn’s 2026 debut in a LinkedIn post Thursday, framing it as a "direct response to Nova’s test announcements."
For more on this story, see Elon Musk’s Billion-Dollar Dominance in SpaceX: Who Else Holds Major Stakes?.
Starship’s Orbital Test Faces Delays While Nova’s Future Hangs in Balance
Starship’s uncrewed orbital test, originally slated for Q4 2025, now faces slippage due to Raptor V2 engine teething issues and Boeing’s SLS delays (which have diverted Starship’s lunar lander contracts to Blue Origin’s Blue Moon). SpaceX’s 2026 financial guidance—shared with NASA’s Commercial Crew Program—projects only 3 Starship launches by year-end, far below the 12 planned in 2024 filings.
Nova’s test does not directly threaten Starship, but it complicates SpaceX’s messaging. In a June 9 earnings call preview, CEO Elon Musk emphasized Starship’s "moonshot" potential, while Nova’s test was described as a "parallel effort"—a framing that contradicts internal emails showing Nova’s team reusing Starship’s Raptor V2 engines, per Aerospace Manufacturing.
Key question: Will Nova cannibalize Starship’s commercial market, or will it free up Starship for NASA and deep-space missions? Analysts at Jefferies predict Nova could capture 20% of the mid-heavy launch market by 2028, but only if SpaceX avoids further delays—a gamble now tied to the IPO’s performance.
Three Critical Factors That Will Shape Nova’s Future and SpaceX’s Market Position
-
Nova’s First Flight (Late 2026 or Early 2027)
- SpaceX has not set a date, but test flight preparations began in May 2026 at Boca Chica, Texas, according to local permitting records.
- Risk: If Nova’s engines underperform, it could delay Starship’s Raptor V2 upgrades, creating a domino effect for both programs.
-
IPO Aftermath: Will Investors Demand Nova Progress?
- Short-term: SpaceX’s stock could volatility spike if Nova’s development is seen as a distraction from Starship.
- Long-term: NASA’s Artemis contracts (worth $4.2 billion) hinge on Starship’s success—Nova’s role remains unclear in public filings.
-
Blue Origin’s New Glenn vs.
- New Glenn’s first launch is now targeted for Q4 2026, per Blue Origin’s May 2026 update, putting it six months ahead of Nova’s projected debut.
- Wildcard: If Nova flies before New Glenn, it could shift commercial satellite contracts—but only if its cost per launch (estimated at $50 million) undercuts competitors.
SpaceX’s Dual-Rocket Strategy Tests Resource Allocation and Investor Confidence
SpaceX’s strategy—dual-developing Nova and Starship—mirrors historical patterns in aerospace, where backup systems (like NASA’s Saturn V and Apollo-era rockets) emerge when primary programs face setbacks. However, analysts at UBS warn that spreading resources thin risks both programs falling behind schedule.
- Will Starship’s orbital test succeed by year-end?
- Can SpaceX maintain investor confidence post-IPO?
- Will Nova’s lower cost make it a viable alternative to Starship for commercial payloads—or will it become a niche player?
One thing is clear: Elon Musk’s IPO gamble now includes Nova as both a hedge and a wildcard—and the market will decide which one it is.
